Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis

Abstract

Brain metastases are a major reason for lung cancer mortality. Here, the authors modify lonidamine to target mitochondria, and show its therapeutic efficacy in inhibiting lung cancer brain metastasis by inducing autophagic cell death in cancer cells.